INHIBITION OF NAD(P)H OXIDASE REDUCES FIBRONECTIN EXPRESSION IN STROKE-PRONE RENOVASCULAR HYPERTENSIVE RAT BRAIN
Authors:
- Alex F ChenACAlex F Chen
- 23 February 2007
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 34 (4) , 304-309
Abstract
1. The aim of the present study was to test the hypothesis that in vivo chronic inhibition of NAD(P)H oxidase reduces cerebrovascular fibronectin expression in stroke-prone renovascular hypertensive rats (RHRSP). 2. The RHRSP model was induced by two clips and NAD(P)H oxidase was inhibited with apocynin. The mRNA and protein expression of NAD(P)H oxidase subunit p22(phox) in brains of RHRSP and Sprague-Dawley (control) rats was determined using real-time reverse transcription-polymerase chain reaction, western blot and immunohistochemistry. The expression of fibronectin protein was localized immunohistochemically in cerebral vessels and then quantified by western blot. 3. Cerebrovascular fibronectin levels in RHRSP (n = 6) were significantly higher than control (n = 5) levels 8 weeks after operation (1.29 +/- 0.04 vs 1.15 +/- 0.02, respectively; P = 0.007). The p22(phox) immunopositive reactivity was localized in the cerebral vasculature of control rats and RHRSP. Furthermore, chronic treatment of RHRSP with apocynin, a selective NAD(P)H oxidase inhibitor, in the drinking water for 4 weeks (1.5 mmol/L, 5 weeks after operation) resulted in a significant decrease in the expression of p22(phox) protein (0.85 +/- 0.01 vs 0.93 +/- 0.01 in non-treated RHRSP; n = 5; P = 0.002), with a concomitant reduction of fibronectin levels in the cerebral vasculature (1.31 +/- 0.03 vs 1.56 +/- 0.05 in non-treated RHRSP; n = 5; P = 0.002). No significant differences were detected in the expression of p22(phox) mRNA and protein between RHRSP (4 and 8 weeks after renal artery constriction) and the control group. 4. These findings suggest that the chronic inhibition of NAD(P)H oxidase in vivo by apocynin reduces cerebrovascular fibronectin levels, which may lessen hypertensive cerebrovascular fibrosis.Keywords
This publication has 30 references indexed in Scilit:
- Endothelin-1 Increases Vascular Superoxide via Endothelin A –NADPH Oxidase Pathway in Low-Renin HypertensionCirculation, 2003
- Upregulation of Nox-Based NAD(P)H Oxidases in Restenosis After Carotid InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Oxidative Stress in Arterial HypertensionHypertension, 2001
- Vascular Remodeling in HypertensionHypertension, 2001
- Molecular Plasticity of Vascular Wall During N G -Nitro- l -Arginine Methyl Ester–Induced HypertensionHypertension, 2000
- Vascular NADH/NADPH Oxidase Is Involved in Enhanced Superoxide Production in Spontaneously Hypertensive RatsHypertension, 2000
- Paracrine Role of Adventitial Superoxide Anion in Mediating Spontaneous Tone of the Isolated Rat Aorta in Angiotensin II-Induced HypertensionHypertension, 1999
- Two-Kidney, Two Clip Renovascular Hypertensive Rats Can Be Used as Stroke-prone RatsStroke, 1998
- Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertensionJournal Of Hypertension, 1996
- Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats.Hypertension, 1993